Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors
Clinical trial NCT01514123 · COMPLETED
Trial details
- NCT number
- NCT01514123
- Sponsor
- Circadian Technologies Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-29
- Primary completion
- 2014-02-07
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.